BIOMAT Database Logo BIOMAT Database Logo

NIDDM associated with mutation in tyrosine kinase domain of insulin receptor gene. 1992

S Cocozza, and A Porcellini, and G Riccardi, and A Monticelli, and G Condorelli, and A Ferrara, and L Pianese, and C Miele, and B Capaldo, and F Beguinot
Department of Cellular and Molecular Biology and Pathology, L. Califano, Centro di Endocrinologia ed Oncologia Sperimentale del Consiglio Nazionale delle Richerche; Naples, Italy.

A population of 103 patients with non-insulin-dependent diabetes mellitus (NIDDM) was screened for mutations in the tyrosine kinase domain of the insulin receptor gene. Patient genomic DNAs corresponding to exons 17-21 of the insulin receptor gene have been amplified by polymerase chain reaction and analyzed by denaturing gradient gel electrophoresis (DGGE). One patient was identified with an altered pattern of mobility of exon 20 in the DGGE assay. Direct sequence of amplified DNA showed a single nucleotide substitution in the codon 1152 (CGG-- greater than CAG), resulting in the replacement of Arg with Gln. Two bands appeared in the sequence of exon 20 of the insulin receptor (nucleotide position 3584), indicating that this patient was heterozygous for the mutation. Insulin binding to intact erythrocytes from the patient was in the normal range. Although autophosphorylation of the purified insulin receptor also seemed normal, its kinase activity toward the exogenous substrate poly Glu:Tyr (4:1) was undetectable. This mutation may impair insulin receptor kinase and contribute to insulin resistance in this patient.

UI MeSH Term Description Entries
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009691 Nucleic Acid Denaturation Disruption of the secondary structure of nucleic acids by heat, extreme pH or chemical treatment. Double strand DNA is "melted" by dissociation of the non-covalent hydrogen bonds and hydrophobic interactions. Denatured DNA appears to be a single-stranded flexible structure. The effects of denaturation on RNA are similar though less pronounced and largely reversible. DNA Denaturation,DNA Melting,RNA Denaturation,Acid Denaturation, Nucleic,Denaturation, DNA,Denaturation, Nucleic Acid,Denaturation, RNA,Nucleic Acid Denaturations
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D011972 Receptor, Insulin A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE. Insulin Receptor,Insulin Receptor Protein-Tyrosine Kinase,Insulin Receptor alpha Subunit,Insulin Receptor beta Subunit,Insulin Receptor alpha Chain,Insulin Receptor beta Chain,Insulin-Dependent Tyrosine Protein Kinase,Receptors, Insulin,Insulin Receptor Protein Tyrosine Kinase,Insulin Receptors
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA

Related Publications

S Cocozza, and A Porcellini, and G Riccardi, and A Monticelli, and G Condorelli, and A Ferrara, and L Pianese, and C Miele, and B Capaldo, and F Beguinot
Human diabetes associated with a mutation in the tyrosine kinase domain of the insulin receptor.
July 1989, Science (New York, N.Y.),
S Cocozza, and A Porcellini, and G Riccardi, and A Monticelli, and G Condorelli, and A Ferrara, and L Pianese, and C Miele, and B Capaldo, and F Beguinot
A mutation in the tyrosine kinase domain of the insulin receptor associated with insulin resistance in an obese woman.
October 1991, The Journal of clinical endocrinology and metabolism,
S Cocozza, and A Porcellini, and G Riccardi, and A Monticelli, and G Condorelli, and A Ferrara, and L Pianese, and C Miele, and B Capaldo, and F Beguinot
A mutation (Trp1193-->Leu1193) in the tyrosine kinase domain of the insulin receptor associated with type A syndrome of insulin resistance.
May 1993, Diabetologia,
S Cocozza, and A Porcellini, and G Riccardi, and A Monticelli, and G Condorelli, and A Ferrara, and L Pianese, and C Miele, and B Capaldo, and F Beguinot
Insulin receptor tyrosine kinase domain auto-dephosphorylation.
December 1992, Biochemical and biophysical research communications,
S Cocozza, and A Porcellini, and G Riccardi, and A Monticelli, and G Condorelli, and A Ferrara, and L Pianese, and C Miele, and B Capaldo, and F Beguinot
Production of inhibitor of insulin-receptor tyrosine kinase in fibroblasts from patient with insulin resistance and NIDDM.
February 1991, Diabetes,
S Cocozza, and A Porcellini, and G Riccardi, and A Monticelli, and G Condorelli, and A Ferrara, and L Pianese, and C Miele, and B Capaldo, and F Beguinot
Substrate specificity of the insulin receptor tyrosine kinase domain.
August 1993, Biochemical Society transactions,
S Cocozza, and A Porcellini, and G Riccardi, and A Monticelli, and G Condorelli, and A Ferrara, and L Pianese, and C Miele, and B Capaldo, and F Beguinot
Insulin-receptor tyrosine kinase activity is decreased in erythrocytes from non-obese patients with NIDDM.
June 1994, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
S Cocozza, and A Porcellini, and G Riccardi, and A Monticelli, and G Condorelli, and A Ferrara, and L Pianese, and C Miele, and B Capaldo, and F Beguinot
Human diabetes associated with a deletion of the tyrosine kinase domain of the insulin receptor.
July 1989, Science (New York, N.Y.),
S Cocozza, and A Porcellini, and G Riccardi, and A Monticelli, and G Condorelli, and A Ferrara, and L Pianese, and C Miele, and B Capaldo, and F Beguinot
Glucagon receptor gene mutation in NIDDM.
February 1996, Diabetologia,
S Cocozza, and A Porcellini, and G Riccardi, and A Monticelli, and G Condorelli, and A Ferrara, and L Pianese, and C Miele, and B Capaldo, and F Beguinot
Identification of an autoinhibitory domain in the insulin receptor tyrosine kinase.
March 1993, Molecular and cellular biochemistry,
Copied contents to your clipboard!